Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Pretta

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|May 20, 2025
The impact of the fetal exposome as a predictor of cancer risk in childhood and adulthood. Aberrant epigenetic events occurring during gestation: May they trigger fetal programming of cancer risk later in life?Gavino Faa, Pina Ziranu, Andrea Pretta, et al.
Human Cell|October 31, 2021
Colorectal cancer promoter methylation alteration affects the expression of glutamate ionotropic receptor AMPA type subunit 4 alternative isoforms potentially relevant in colon tissueAna Florencia Vega-Benedetti, Eleonora Loi, Loredana Moi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 15, 2025
Cancer-associated fibroblasts (CAFs) and plaque-associated fibroblasts (PAFs): Unraveling the cellular crossroads of atherosclerosis and cancerGavino Faa, Pina Ziranu, Andrea Pretta, et al.
Frontiers in Oncology|February 15, 2021
Immune Checkpoint Inhibitors in the Treatment of HCCClelia Donisi, Marco Puzzoni, Pina Ziranu, et al.
World Journal of Hepatology|September 26, 2022
Hepatocellular carcinoma and microbiota: Implications for clinical management and treatmentDario Spanu, Andrea Pretta, Eleonora Lai, et al.
Cancers|April 14, 2026
Integrating Artificial Intelligence into Breast Cancer Histopathology: Toward Improved Diagnosis and PrognosisGavino Faa, Eleonora Lai, Flaviana Cau, et al.
Expert Review of Molecular Diagnostics|May 1, 2018
BRAF-mutant colorectal cancer, a different breed evolvingEleonora Lai, Andrea Pretta, Valentino Impera, et al.
Clinical Colorectal Cancer|July 8, 2020
MOMENTUM: A Phase I Trial Investigating 2 Schedules of Capecitabine With Aflibercept in Patients With Gastrointestinal and Breast CancerSilvia Camera, Amélie Deleporte, Giacomo Bregni, et al.
Frontiers in Oncology|October 18, 2021
Retrospective Comparative Analysis of KRAS G12C <i>vs</i>. Other KRAS Mutations in mCRC Patients Treated With First-Line Chemotherapy Doublet + BevacizumabRiccardo Giampieri, Alessio Lupi, Pina Ziranu, et al.
International Journal of Molecular Sciences|August 14, 2025
Navigating the Landscape of Liquid Biopsy in Colorectal Cancer: Current Insights and Future DirectionsPina Ziranu, Andrea Pretta, Giorgio Saba, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|May 20, 2025
The impact of the fetal exposome as a predictor of cancer risk in childhood and adulthood. Aberrant epigenetic events occurring during gestation: May they trigger fetal programming of cancer risk later in life?Gavino Faa, Pina Ziranu, Andrea Pretta, et al.
Human Cell|October 31, 2021
Colorectal cancer promoter methylation alteration affects the expression of glutamate ionotropic receptor AMPA type subunit 4 alternative isoforms potentially relevant in colon tissueAna Florencia Vega-Benedetti, Eleonora Loi, Loredana Moi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 15, 2025
Cancer-associated fibroblasts (CAFs) and plaque-associated fibroblasts (PAFs): Unraveling the cellular crossroads of atherosclerosis and cancerGavino Faa, Pina Ziranu, Andrea Pretta, et al.
Frontiers in Oncology|February 15, 2021
Immune Checkpoint Inhibitors in the Treatment of HCCClelia Donisi, Marco Puzzoni, Pina Ziranu, et al.
World Journal of Hepatology|September 26, 2022
Hepatocellular carcinoma and microbiota: Implications for clinical management and treatmentDario Spanu, Andrea Pretta, Eleonora Lai, et al.
Cancers|April 14, 2026
Integrating Artificial Intelligence into Breast Cancer Histopathology: Toward Improved Diagnosis and PrognosisGavino Faa, Eleonora Lai, Flaviana Cau, et al.
Expert Review of Molecular Diagnostics|May 1, 2018
BRAF-mutant colorectal cancer, a different breed evolvingEleonora Lai, Andrea Pretta, Valentino Impera, et al.
Clinical Colorectal Cancer|July 8, 2020
MOMENTUM: A Phase I Trial Investigating 2 Schedules of Capecitabine With Aflibercept in Patients With Gastrointestinal and Breast CancerSilvia Camera, Amélie Deleporte, Giacomo Bregni, et al.
Frontiers in Oncology|October 18, 2021
Retrospective Comparative Analysis of KRAS G12C <i>vs</i>. Other KRAS Mutations in mCRC Patients Treated With First-Line Chemotherapy Doublet + BevacizumabRiccardo Giampieri, Alessio Lupi, Pina Ziranu, et al.
International Journal of Molecular Sciences|August 14, 2025
Navigating the Landscape of Liquid Biopsy in Colorectal Cancer: Current Insights and Future DirectionsPina Ziranu, Andrea Pretta, Giorgio Saba, et al.
Pageof 6